亚洲精品成人免费_91女神娇喘疯狂3p之夜_精品韩国一级久久_av毛片网_www超碰com_午夜视频体内射.COM.COM

美國NuSep
NuSep的歷史可以追溯到Dr Joel Margolis and Dr Perry Manusu在1970年代早期的生物分離工作。通過他們的合作，生產出第一臺梯度凝膠，第一臺微型凝膠和第一臺產業規模電泳分離系統。 這兩位先生的智慧以及探索精神使得NuSep成為在生物分離市場首屈一指的技術供應商。

主營產品：
生物分離設備

NuSep (ASX: NSP) is a publicly listed life sciences company that sells products into the global BioSeparations market. NuSep has offices in both Sydney Australia and Athens GA, USA.

With a 30 year heritage in biological separations, NuSep has forged a world class reputation for its innovative yet simple solutions to biological separation problems including the world's first IVF sperm separation device. NuSep's nUView Gels and ProteoIQ software are both 'Best of Class' worldwide. In short NuSep has redefined the BioSeparations market through innovation and simplification.

NuSep's world renowned research team has developed an extensive portfolio of patented products. In all, NuSep currently manufactures, distributes and sells 55 products to customers in the USA, Europe, Asia and Australia.

History

NuSep traces its roots back to Dr Joel Margolis and Dr Perry Manusu's pioneer biological separation work in the early 1970's. This productive partnership produced the first gradient gel, the first micro gel and the first industrial scale electrophoresis separation system. NuSep owes a considerable intellectual debt to these two gentlemen and is using this solid intellectual capital foundation to become the premier technology supplier in the BioSeparations market.

In this time the Company has had many world firsts including:

First gradient gel in 1969;
First Highly crosslinked gel 1980;
First continuous flow membrane fraction system 1984;
First micro gel in 1988;
First solid wells in precast gels 1993;
First large scale gel manufacturing system 1995;
First micro membrane fractionation system 2005;
First electrical separation of sperm 2005;
First SpermSep clinical trial at Westmead Fertility Centre 2008;
Launch of the ProteomeSep instrument 2010;
Launch of the nUView Gels 2010;
Launch of the ProteoIQ preoteomics software 2010;
Launch of long life Tris-Glycine Gels 2011.

From the outset, NuSep was founded as a life science company with a mission to redefine the Biological Separations market based on our novel technology.

NuSep will continue to provide the same high quality service and innovative products for biological separations recognised by scientists for over 30 years.

Vision

NuSep's vision is:

To be the Premier Technology Supplier in the BioSeparations market.

This new vision emphasises the value of the technology platform and delivering new opportunities, such as SingaPharm, based on this technology platform.

Goals

NuSep has two primary goals which it is aiming to achieve. These are:

To grow NuSep so that it has yearly sales of $100 million and $20 million in profit per annum within 5 years; and

To become an ASX Top 300 company.